NuGen Medical Devices Inc. NGMD.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 107.30K | 119.60K | 183.00K | 419.60K | 784.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.30K | 119.60K | 183.00K | 419.60K | 784.30K |
| Cost of Revenue | 55.90K | 60.60K | 89.10K | 188.90K | 377.30K |
| Gross Profit | 51.30K | 58.90K | 93.80K | 230.60K | 407.00K |
| SG&A Expenses | 3.10M | 2.99M | 2.75M | 2.68M | 3.44M |
| Depreciation & Amortization | 283.20K | 383.30K | 371.70K | 341.20K | 455.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.44M | 3.44M | 3.21M | 3.21M | 4.27M |
| Operating Income | -3.33M | -3.32M | -3.03M | -2.79M | -3.49M |
| Income Before Tax | -6.96M | -7.92M | -5.64M | -1.58M | -2.39M |
| Income Tax Expenses | 31.80K | 34.50K | 37.20K | -400.00 | 10.80K |
| Earnings from Continuing Operations | -6.99 | -7.95 | -5.67 | -1.58 | -2.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.99M | -7.95M | -5.67M | -1.58M | -2.40M |
| EBIT | -3.33M | -3.32M | -3.03M | -2.79M | -3.49M |
| EBITDA | -2.93M | -2.81M | -2.53M | -2.31M | -3.02M |
| EPS Basic | -0.03 | -0.04 | -0.03 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.04 | -0.03 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 908.14M | 908.14M | 907.58M | 900.00M | 890.28M |
| Average Diluted Shares Outstanding | 908.14M | 908.14M | 907.58M | 900.00M | 890.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |